Increase in mortality rate following coprescription of cisapride and contraindicated drugsCHOI, Nam-Kyong; HAHN, Seokyung; PARK, Byung-Joo et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 4, pp 667-673, issn 1060-0280, 7 p.Article

Cochrane's epitaph for cisapride in childhood gastro-oesophageal refluxBOURKE, B; DRUMM, B.Archives of disease in childhood. 2002, Vol 86, Num 2, pp 71-72, issn 0003-9888Article

Applications des techniques d'électromyographie et de manométrie de l'intestin grêle à l'étude de la pharmacologie de la motricité intestinale chez l'hommeChaussade, Stanislas; Couturier, Daniel.1989, 197 p.Thesis

Les nouvelles conditions de prescription du Prepulsid® = New conditions for prescribing PrepulsidBUXERAUD, J.Archives de pédiatrie (Paris). 2003, Vol 10, Num 6, pp 579-582, issn 0929-693X, 4 p.Article

Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux diseaseCARMAGNOLA, Stefania; FRAQUELLI, Mirella; CANTU, Paolo et al.Scandinavian journal of gastroenterology. 2006, Vol 41, Num 7, pp 767-772, issn 0036-5521, 6 p.Article

Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placeboZIEGENHAGEN, Dieter J; KRUIS, Wolfgang.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 7, pp 744-749, issn 0815-9319, 6 p.Article

Cisapride : a gastrointestinal prokinetic drugBARONE, J. A; JESSEN, L. M; COLAIZZI, J. L et al.The Annals of pharmacotherapy. 1994, Vol 28, Num 4, pp 488-500, issn 1060-0280Article

The effect of safe experience on a warnings' impact : Sex, drugs, and rock-n-rollBARRON, Greg; LEIDER, Stephen; STACK, Jennifer et al.Organizational behavior and human decision processes (Print). 2008, Vol 106, Num 2, pp 125-142, issn 0749-5978, 18 p.Article

Cisapride may improve feeding tolerance of preterm infants : A randomized placebo-controlled trialKOHL, Martina; WUERDEMANN, Iris; CLEMEN, Jessica et al.Biology of the neonate. 2005, Vol 88, Num 4, pp 270-277, issn 0006-3126, 8 p.Article

24-Hour electrocardiogram before and during cisapride treatment in neonates and infantsZAMORA, Samuel A; BELLI, Dominique C; FRIEDLI, Beat et al.Biology of the neonate. 2004, Vol 85, Num 4, pp 229-236, issn 0006-3126, 8 p.Article

Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338FURUTA, Shigeru; KAMADA, Emiko; OMATA, Takeshi et al.European journal of pharmacology. 2004, Vol 497, Num 2, pp 223-231, issn 0014-2999, 9 p.Article

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride)JIAN, R; DUCROT, F; PIEDELOUP, C et al.Gut. 1985, Vol 26, Num 4, pp 352-358, issn 0017-5749Article

Treatment of functional dyspepsia with serotonin agonists : A meta-analysis of randomized controlled trialsHIYAMA, Toru; YOSHIHARA, Masaharu; MATSUO, Keitaro et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 10, pp 1566-1570, issn 0815-9319, 5 p.Article

Movement disorders induced by gastrointestinal drugs : Two paediatric casesELZINGA-HUTTENGA, J; HEKSTER, Y; BLJI, A et al.Neuropediatrics. 2006, Vol 37, Num 2, pp 102-106, issn 0174-304X, 5 p.Article

Determination of cisapride, its oxidation product, propyl and butyl parabens in pharmaceutical dosage form by reversed-phase liquid chromatographyBELGAIED, J.-E; TRABELSI, H.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 5, pp 991-998, issn 0731-7085, 8 p.Article

Intrauterine growth retardation is a risk factor for cisapride-induced QT prolongation in preterm infantsCORVAGLIA, Luigi; FALDELLA, Giacomo; ROTATORI, Raffaella et al.Cardiovascular drugs and therapy. 2004, Vol 18, Num 5, pp 371-375, issn 0920-3206, 5 p.Article

A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infantsCOOLS, Filip; BENATAR, Avram; BRUNEEL, Els et al.European journal of clinical pharmacology. 2003, Vol 59, Num 1, pp 17-22, issn 0031-6970, 6 p.Article

The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsiaBESHERDAS, K; LEAHY, A; MASON, I et al.Alimentary pharmacology & therapeutics. 1998, Vol 12, Num 8, pp 755-759, issn 0269-2813Article

Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection : application to pharmacokinetic studyDESTA, Z; SOUKHOVA, N. V; MOROCHO, A et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 744, Num 2, pp 263-272, issn 1387-2273Article

Population pharmacokinetics of cisapride in neonatesODOUL, F; LE GUELLEC, C; HENROT, A et al.European journal of clinical pharmacology. 2002, Vol 58, Num 8, pp 507-513, issn 0031-6970, 7 p.Article

High performance liquid chromatographic determination, pharmacokinetic and comparative bioavailability studies of cisaprideEMAMI, J; VARSHOSAZ, J; FALAMARZIAN, M et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 3, pp 513-520, issn 0731-7085, 8 p.Article

Interaction of cisapride with the human cytochrome P450 system : Metabolism and inhibition studiesDESTA, Z; SOUKHOVA, N; MAHAL, S. K et al.Drug metabolism and disposition. 2000, Vol 28, Num 7, pp 789-800, issn 0090-9556Article

Proarrhythmia associated with cisapride in childrenHILL, S. L; EVANGELISTA, J.-A. K; PIZZI, A. M et al.Pediatrics (Evanston). 1998, Vol 101, Num 6, pp 1053-1056, issn 0031-4005Article

Effects of cisapride on QTc interval in neonatesBERNARDINI, S; SEMAMA, D. S; HUET, F et al.Archives of disease in childhood. Fetal and neonatal edition. 1997, Vol 77, Num 3, pp F241-F243, issn 1359-2998Article

Use of cisapride. Authors' replyMATHEW, Alexander; DEORARI, A. K; REDDY, P. S et al.Indian pediatrics. 2000, Vol 37, Num 12, pp 1402-1404, issn 0019-6061Article